title: Low-grade serous carcinoma of the ovary displaying a macropapillary pattern of invasion.
abstract: Invasive micropapillary serous carcinoma (MPSC) also designated "low-grade serous carcinoma" (LGSC) of the ovary is characterized by small micropapillae that infiltrate underlying tissue (ovarian stroma). On occasion these tumors in addition to the micropapillae contain large macropapillae lined by bland epithelium. In rare cases, the entire tumor is composed of macropapillae. In these cases, the question of whether this is an invasive carcinoma or an unusual type of adenofibroma has been raised. The goal of this study was to describe this unusual macropapillary pattern of invasion in LGSC. Cases of LGSC containing macropapillae were retrieved from the files of the Johns Hopkins Hospital. In addition to a detailed morphologic analysis, the mutational status of KRAS and BRAF in the macropapillary, noninvasive, and invasive MPSC components was analyzed by nucleotide sequencing. There were 14 cases containing macropapillae (11 cases of LGSC, 2 cases of atypical proliferative serous tumor (APST) with microinvasion, and 1 case of APST with a focus of LGSC with macropapillae in perivaginal soft tissue). In 3 cases, extraovarian metastases contained macropapillae. Molecular analysis of the primary tumor components (macropapillary, noninvasive, and invasive MPSC and/or APST) was performed in 7 cases and of a lymph node metastasis with macropapillae in 1 case. The identical KRAS mutation was detected in all of the analyzed components of the primary ovarian tumors in 4 cases. In one of these cases, macropapillae in the lymph node metastasis contained a KRAS mutation identical to the primary tumor. The BRAF mutation identified in 1 case was identical in all components of the ovarian tumor. The identical mutations in the macropapillae and the other tumor components in each case indicate that they are clonally related. The finding of macropapillae within lymph nodes supports the interpretation that the macropapillary component is another manifestation of invasion in LGSC. The recognition of this pattern is important, especially in cases when a tumor is composed entirely of macropapillae.
authors.affiliation: Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD 21231, USA. ayemely1@jhmi.edu
authors.forename: Anna
authors.initials: A
authors.lastname: Yemelyanova
authors.forename: Tsui-Lien
authors.initials: TL
authors.lastname: Mao
authors.forename: Naomi
authors.initials: N
authors.lastname: Nakayama
authors.forename: Ie Ming
authors.initials: IeM
authors.lastname: Shih
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Kurman
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018284:Cystadenocarcinoma, Serous / Q000235:genetics / Q000473:pathology*; D004252:DNA Mutational Analysis; D005260:Female; D006801:Humans; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000235:genetics / Q000473:pathology*; D010051:Ovarian Neoplasms / Q000235:genetics / Q000473:pathology*; D011518:Proto-Oncogene Proteins / Q000235:genetics; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins / Q000235:genetics
chemical_list: C117307:KRAS protein, human; D011518:Proto-Oncogene Proteins; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins
references.citation: Am J Pathol. 2004 May;164(5):1511-8
references.pmid: 15111296
references.citation: J Pathol. 2004 Mar;202(3):336-40
references.pmid: 14991899
references.citation: Am J Surg Pathol. 2007 Feb;31(2):161-9
references.pmid: 17255760
references.citation: Am J Surg Pathol. 2001 Apr;25(4):419-32
references.pmid: 11257616
references.citation: Clin Med Res. 2007 Mar;5(1):35-44
references.pmid: 17456833
references.citation: J Pathol. 2006 Dec;210(4):405-11
references.pmid: 17096315
references.citation: Cancer. 1994 Apr 1;73(7):1859-64
references.pmid: 8137211
references.citation: Gynecol Oncol. 2006 Dec;103(3):883-7
references.pmid: 16806438
references.citation: Int J Gynecol Pathol. 2008 Jan;27(1):1-9
references.pmid: 18156967
references.citation: J Natl Cancer Inst. 2003 Mar 19;95(6):484-6
references.pmid: 12644542
references.citation: J Pathol. 2007 Jan;211(1):26-35
references.pmid: 17117391
references.citation: Am J Surg Pathol. 1996 Nov;20(11):1319-30
references.pmid: 8898836
references.citation: Am J Surg Pathol. 2003 Jun;27(6):725-36
references.pmid: 12766576
references.citation: Am J Surg Pathol. 2005 Feb;29(2):218-24
references.pmid: 15644779
references.citation: Am J Surg Pathol. 1996 Nov;20(11):1331-45
references.pmid: 8898837
references.citation: Am J Pathol. 2002 Apr;160(4):1223-8
references.pmid: 11943707
references.citation: Clin Cancer Res. 2005 Oct 15;11(20):7273-9
references.pmid: 16243797
references.citation: Curr Opin Obstet Gynecol. 2007 Feb;19(1):3-9
references.pmid: 17218844
references.citation: Int J Gynecol Pathol. 2003 Jan;22(1):37-41
references.pmid: 12496696
references.citation: Adv Anat Pathol. 2006 Jan;13(1):1-7
references.pmid: 16462151
references.citation: J Pathol. 2004 Jun;203(2):617-9
references.pmid: 15141374
references.citation: J Cell Biochem Suppl. 1995;23:208-18
references.pmid: 8747398
references.citation: Hum Pathol. 2004 Aug;35(8):934-48
references.pmid: 15297961